about
Wider action plan and multidisciplinar approach could be a wining idea in creation of friendly environment.Simultaneous genotyping of GSTT1 and GSTM1 null polymorphisms by melting curve analysis in presence of SYBR Green I.Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis.Effect of occupational exposure to cytostatics and nucleotide excision repair polymorphism on chromosomal aberrations frequency.Microfluidic force spectroscopy for characterization of biomolecular interactions with piconewton resolution.Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studiesMicronuclei levels in peripheral blood lymphocytes as a potential biomarker for pancreatic cancer risk.DNA repair genes XRCC1 and XRCC3 polymorphisms and their relationship with the level of micronuclei in breast cancer patientsBiomonitoring of human exposure to prestige oil: effects on DNA and endocrine parameters.Association of the glutathione s-transferase m1, t1 polymorphisms with cancer: evidence from a meta-analysis.Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) null polymorphisms and the risk of hypertension: a meta-analysisPolymorphisms of phase II xenobiotic-metabolizing and DNA repair genes and in vitro N-ethyl-N-nitrosourea-induced O6-ethylguanine levels in human lymphocytes.Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancerHuman population studies with cytogenetic biomarkers: review of the literature and future prospectives.Occupational exposure of workers to pesticides: Toxicogenetics and susceptibility gene polymorphisms.Styrene metabolism, genotoxicity, and potential carcinogenicity.The cellular and molecular carcinogenic effects of radon exposure: a review.Association between frequency of chromosomal aberrations and cancer risk is not influenced by genetic polymorphisms in GSTM1 and GSTT1.PAH biomarkers for human health risk assessment: a review of the state-of-the-art.Patterns of persistent DNA damage associated with sun exposure and the glutathione S-transferase M1 genotype in melanoma patients.Role of p53 codon 72 polymorphism in chromosomal aberrations and mitotic index in patients with chronic hepatitis B.Electrical detection of protein biomarkers using bioactivated microfluidic channels.Cytogenetic instability in childhood acute lymphoblastic leukemia survivors.Polymorphisms of GSTM1, GSTT1, GSTP1 genes and chromosomal aberrations in lung cancer patients.Combinations of genotoxic tests for the evaluation of group 1 IARC carcinogens.Studying the effect of antioxidants on cytogenetic manifestations of solvent exposure in the paint industry.Workers exposed to wood dust have an increased micronucleus frequency in nasal and buccal cells: results from a pilot study.Genetic Contribution of Polymorphisms in Glutathione S-Transferases to Brain Tumor Risk.A combination of micronucleus assay and fluorescence in situ hybridization analysis to evaluate the genotoxicity of formaldehyde.Evaluation of primary DNA damage, cytogenetic biomarkers and genetic polymorphisms for CYP1A1 and GSTM1 in road tunnel construction workers.The effect of genetic admixture in an association study: genetic polymorphisms and chromosome aberrations in a Colombian population exposed to organic solvents.Molecular mechanisms of action of styrene toxicity in blood plasma and liver.Re-examination of the genotoxic activity of water taken from the Songhua River in P. R. China.Noninvasive identification of interindividual variation in xenobiotic-metabolizing enzymes: implications for cancer epidemiology and biomarker studies.Assessment of in vitro cytotoxic and genotoxic activities of some trimethoprim conjugates.Glutathione S-transferase M1, T1, and P1 polymorphisms and risk of glioma: a meta-analysis.The influence on DNA damage of glycaemic parameters, oral antidiabetic drugs and polymorphisms of genes involved in the DNA repair system.DNA excision repair and double-strand break repair gene polymorphisms and the level of chromosome aberration in children with long-term exposure to radon.Polymorphism in glutathione S-transferases: susceptibility and treatment outcome for head and neck cancer.Assessment of primary, oxidative and excision repaired DNA damage in hospital personnel handling antineoplastic drugs.
P2860
Q28731241-DD75C7EC-07C7-475A-83E1-0A3890E00070Q33813842-048867F6-9E9D-4BCB-9AD1-54EDE1981521Q33918340-96E71606-F368-4FF5-8482-0C9E66D935BEQ34320010-F347761E-F5D7-4EFE-ABDE-76BFB87D97A5Q34335987-C3F6FF9B-5460-46B6-8FE7-D22326E3CD2FQ34494142-E15F3382-A9DB-4586-BD9A-31E7D987C75CQ34520438-03E0C804-E0FA-4249-B31F-68C66BF0BEDDQ34562923-F6D214AD-BE7D-4E9B-B1F5-1F6905293A54Q34964796-53EA570B-55D7-484B-A211-AA4ACF6D2026Q35046622-7D4C5429-F76B-4196-B747-CF3FEFE40F2FQ35572325-63FDE74D-A4CD-4AC5-AEF1-6C69ACC8FAC4Q35688348-6EF09849-60EA-469B-9753-616B03AB5BD9Q35842688-D60E844A-84C1-42DC-955B-1DD638C350E4Q36028399-9C6712BF-D9AD-42B4-9A0B-930CC76DD7A9Q36182047-31EADF2D-28DE-47DE-A3D9-E54760E6D67EQ36673612-C291757F-8230-4EF2-B2F9-9E1E3AA09AA7Q37091897-DE35AE97-F97A-49E3-8668-731467C20643Q37112512-EAD4C103-CFC4-4EA5-AF23-DDA00C3EC15FQ37271664-2BFBF0A4-0A42-41C2-B368-1364E5CB477CQ37346886-E9CA4521-2AFD-4870-A1FD-4FC31917E324Q37370785-99F0526F-49E2-431B-935B-D34402C72D5AQ37423868-BDB1A190-5DC8-4E6A-B9E2-3720BFEDC0F3Q37792821-1F995BEB-4C82-455A-8173-3A555F3FFFE6Q38645223-7258D8F6-96F2-4470-94E9-84A0338C7CE8Q38684576-0B694DFC-8C22-4AA8-B4A2-4D1C59DBEDFCQ38985559-4EAFB368-759B-48F7-A309-D7AB9EDC7866Q39236966-5F8906B2-2762-43E3-807D-3F2EFCA913DDQ41310566-34398EEB-209B-40D9-9594-183BED8F8058Q43868707-9500355D-845E-4FB2-B8C2-D99654F0698CQ44188146-FE1CBFE1-14E4-4756-B1FB-1BDC1FD2359FQ45684129-FE696732-52AC-40DC-82D7-A33D9A2CE874Q46340437-A85115C3-6BBB-4C62-A9AE-E6B0DDF3E322Q46539763-13D18784-4814-4A30-90D2-9AD754A5A38AQ48086965-0A49B42D-258A-4BF9-BCD2-43BCE4627FA4Q48239016-389C3277-204E-49E4-852B-E89FE31803B8Q48329963-E5B5A810-E4FB-4455-AFF8-13E1FFFE00D6Q50884511-CB2290CD-C27C-4F42-8577-BD27B8A0529CQ51710010-5C7CA472-8E3D-4C33-A333-6EBCB80D0BB2Q51852328-37420D99-05C6-4231-B413-F0A1B4A441ADQ53163487-5E0A64B2-9F4B-4460-B77D-532335E2CDD3
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cytogenetic biomarkers and genetic polymorphisms.
@ast
Cytogenetic biomarkers and genetic polymorphisms.
@en
type
label
Cytogenetic biomarkers and genetic polymorphisms.
@ast
Cytogenetic biomarkers and genetic polymorphisms.
@en
prefLabel
Cytogenetic biomarkers and genetic polymorphisms.
@ast
Cytogenetic biomarkers and genetic polymorphisms.
@en
P1433
P1476
Cytogenetic biomarkers and genetic polymorphisms.
@en
P2093
Hannu Norppa
P304
P356
10.1016/J.TOXLET.2003.12.042
P577
2004-04-01T00:00:00Z